Latest Breaking News On - தொழில்நுட்பம் வாட்ச் - Page 1 : comparemela.com

Nutra Pharma Corporation: Nutra Pharma Letter to Shareholders Plantation, Florida (Newsfile Corp. - January 12, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company s Chief Executive Officer, Rik J Deitsch, has published a Letter to Shareholders on the Company s website. The last year was a challenging one for all businesses but was certainly a very busy year at Nutra Pharma, explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. Regardless of the global pandemic and economic downturn, Nutra Pharma was able to create new opportunities for our products and technologies. This has provided a strong platform for real growth in 2021, he continued. I wanted to take this opportunity to update o

United statesCoral springsNina goldsteinDale vanderputtenNutra pharmaNutra pharma corpNutra pharma corporationNutra pharma the companyFlorida newsfile corpDefense threat reduction agencyPharma corporationPet pain awayEquine pain awayMultiple sclerosisHuman immunodeficiency virusChief executive officer